Jefferies eleva preço-alvo da Immuneering para US$ 3,50 após dados de câncer – Investing.com Brasil – Finanças, Câmbio e Investimentos

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.